- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
ニュース
Recognition
4月 9, 2021
Cybersecurity Docket Names Robert Hudock and Phyllis Sumner to its Incident Response 30 List
Recognition
4月 8, 2021
Le Point Magazine Again Recognizes King & Spalding Among the Top Law Firms in France
Recognition
4月 7, 2021
The American Lawyer Names Javier Rubinstein a 2021 Midwest Trailblazer
Recognition
4月 7, 2021
King & Spalding Wins Saudi Arabia Client Service Award at Chambers Middle East Awards 2021
インサイト
Article
4月 24, 2021
Pitfalls of Unequal Participation Rights in Syndicated DIP Financing
COVID-19 Vaccine Updates
4月 9, 2021
Australia Asks EU to Remove Barriers and Ship COVID-19 Vaccine Doses
COVID-19 Vaccine Updates
4月 9, 2021
CDC Awards $3 Billion to Expand COVID-19 Vaccine Programs
COVID-19 Vaccine Updates
4月 9, 2021
HHS Launches COVID-19 Community Corps
ニュース
Recognition
4月 9, 2021
Cybersecurity Docket Names Robert Hudock and Phyllis Sumner to its Incident Response 30 List
Recognition
4月 8, 2021
Le Point Magazine Again Recognizes King & Spalding Among the Top Law Firms in France
Recognition
4月 7, 2021
The American Lawyer Names Javier Rubinstein a 2021 Midwest Trailblazer
Recognition
4月 7, 2021
King & Spalding Wins Saudi Arabia Client Service Award at Chambers Middle East Awards 2021
Media Contacts
Micheline S. Tang
Director of Communications
+1 212 556 2301
Antony Collins
Public Relations Manager
+ 44 207 551 2153
Luis Mocete
Public Relations Manager
+1 212 827 4008
Jessie Seyfer
Public Relations Manager
+1 415 318 1223
King & Spalding Preferences Center
Register and SubscribeChina Subsidy Exchange
Read moreCOVID-19 Vaccine Updates
Read moreEnergy Law Exchange
Read MoreK&S Perspectives Podcast Series
Read MoreContacts
Micheline S. Tang
Director of Communications
+1 212 556 2301
Antony Collins
Public Relations Manager
+ 44 207 551 2153
Luis Mocete
Public Relations Manager
+1 212 827 4008
Jessie Seyfer
Public Relations Manager
+1 415 318 1223